Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

MIRAPEXIN 2.1 mg prolonged-release tablets

Active Ingredient:
pramipexole dihydrochloride monohydrate
Company:  
Boehringer Ingelheim Limited See contact details
ATC code: 
N04BC05
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Safety Alert HCP Med Info
{arrow_left}
{arrow_right}
Dopamine agonists: pathological gambling, increased libido, and hypersexuality (MHRA release December 2014)

Healthcare professionals should warn patients that compulsive behaviour with dopamine agonists may be dose-related. Evidence suggests that pathological gambling and increased libido, including hypersexuality, may be rare class effects of dopamine agonists.

Further information can be found in the MHRA Drug Safety Update
Boehringer Ingelheim Limited
Company image
Address
Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS
WWW
http://www.boehringer-ingelheim.co.uk
Telephone
+44 (0)1344 424 600
Fax
01344 741444
Medical Information Direct Line
+44 (0)1344 742579
Medical Information e-mail
[email protected]